Home › Funds › Squadron Capital Management LLC › CBIO
Squadron Capital Management LLC position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
Squadron Capital Management LLC reported holding 350,000 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 2.02% of its reported portfolio and ranking #18 among its reported holdings. Squadron Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's CBIO position evolved
Squadron Capital Management LLC first disclosed a stake in CBIO in Q3 2026 at 350,000 shares (US$5.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 350.00K | $5.11M | New |
About CBIO and 13F data
CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 66 other funds we track also report a position in CBIO — the largest reported positions include Fairmount Funds Management LLC (US$52.5M), BVF INC/IL (US$45.1M), Vestal Point Capital, LP (US$43.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CBIO
- Fairmount Funds Management LLC 3.60M sh · $52.54M · Q3 2026
- BVF INC/IL 3.09M sh · $45.14M · Q3 2026
- Vestal Point Capital, LP 3.00M sh · $43.77M · Q3 2026
- Venrock Adviser, LLC 2.13M sh · $31.13M · Q3 2026
- FCPM III SERVICES B.V. 2.02M sh · $29.51M · Q3 2026
- Opaleye Management Inc. 1.32M sh · $23.75M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.16M sh · $16.92M · Q3 2026
- Logos Global Management LP 850.00K sh · $12.40M · Q3 2026
- NEXTBio Capital Management LP 372.86K sh · $5.44M · Q3 2026
- Remedium Capital Partners, LLC 361.25K sh · $5.27M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 279.72K sh · $4.08M · Q3 2026
- Boxer Capital Management, LLC 226.84K sh · $3.31M · Q3 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held CBIO?
Squadron Capital Management LLC has disclosed CBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Squadron Capital Management LLC's current position in CBIO?
As of Q3 2026, Squadron Capital Management LLC holds 350.00K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $5.11M, representing 2.02% of its reported portfolio and ranking #18.
Has Squadron Capital Management LLC been buying or selling CBIO?
In the latest 13F filing (Q3 2026), Squadron Capital Management LLC newly opened its position in CBIO.
Which other funds hold CBIO?
Other major institutional holders of CBIO include Fairmount Funds Management LLC, BVF INC/IL, Vestal Point Capital, LP, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.